Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Tozadenant

Generic Name: Tozadenant

Drug Type: Small Molecule

Chemical Formula: C_₁₉H_₂₆N_₄O_₄S

CAS Number: 870070-55-6

Unique Ingredient Identifier: D9K857J81I

Overview

Tozadenant has been investigated for the basic science of Cocaine Dependence.

Background

Tozadenant has been investigated for the basic science of Cocaine Dependence.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Study to Investigate the Influence of Hepatic Insufficiency on the Pharmacokinetics of Tozadenant

Phase 1

Terminated

Posted: 2017/07/11

Sponsor:

Biotie Therapies Inc...

ID:NCT03212313

A Study to Determine the Abuse Potential of Tozadenant Relative to D-Amphetamine and Placebo When Administered Orally in Healthy, Non-Dependent, Recreational Polydrug Users

Phase 1

Terminated

Posted: 2017/06/27

Sponsor:

Biotie Therapies Inc...

ID:NCT03200080

Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease.

Phase 3

Terminated

Posted: 2017/02/13

Sponsor:

Biotie Therapies Inc...

ID:NCT03051607

Safety and Efficacy Study of Tozadenant to Treat End of Dose Wearing Off in Parkinson's Patients

Phase 3

Terminated

Posted: 2015/05/25

Sponsor:

Biotie Therapies Inc...

ID:NCT02453386

Study to Evaluate the Absorption, Distribution, Break Down and Elimination and the Safety of 14C-Labeled Tozadenant

Phase 1

Completed

Posted: 2014/09/15

Sponsor:

Biotie Therapies Inc...

ID:NCT02240290

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy